# Fidelity D & D Bancorp Inc: overview

FDBC · Nasdaq · CIK 1098151 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/fdbc.md) · [Financials](/companies/fdbc/financials.md) · [Filings](/companies/fdbc/filings.md) · [Insiders](/companies/fdbc/insiders.md)

Revenue is not reported in this company’s XBRL financial statements.

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [0.86](/filings/0001437749-25-033855.md) | not reported | [1.03](/filings/0001437749-26-015900.md) | [1.20](/filings/0001437749-26-026575.md) | [1.27](/filings/0001437749-25-033855.md) | not reported | [1.28](/filings/0001437749-26-015900.md) | [1.33](/filings/0001437749-26-026575.md) |
| Free cash flow | $m | [7.8 d](/filings/0001437749-25-033855.md) | [5.9 d](/filings/0001437749-26-008215.md) | [11.5](/filings/0001437749-26-015900.md) | [6.9 d](/filings/0001437749-26-026575.md) | [2.2 d](/filings/0001437749-25-033855.md) | [4.2 d](/filings/0001437749-26-008215.md) | [3.3](/filings/0001437749-26-015900.md) | [17.1 d](/filings/0001437749-26-026575.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | not reported |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | not reported | not reported | not reported | not reported | not reported |
| Diluted EPS | $ per share | [4.48](/filings/0001437749-23-007221.md) | [5.29](/filings/0001437749-24-008680.md) | [3.19](/filings/0001437749-25-007555.md) | [3.60](/filings/0001437749-26-008215.md) | [4.86](/filings/0001437749-26-008215.md) |
| Free cash flow | $m | [4.7](/filings/0001437749-23-007221.md) | [43.9](/filings/0001437749-24-008680.md) | [22.7](/filings/0001437749-25-007555.md) | [24.9](/filings/0001437749-26-008215.md) | [24.8](/filings/0001437749-26-008215.md) |

- Revenue. XBRL not reported.
- Gross margin (gross profit / revenue). XBRL not reported.
- Operating margin (operating income / revenue). XBRL not reported.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/fdbc/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $17.7m | 345,008 |  | Added +42,560 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $10.0m | 194,785 |  | Added +82 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $6.3m | 121,639 |  | Added +8,495 |
| [FIDELITY D & D BANCORP INC](/funds/1098151.md) | 2026-06-30 | $4.9m | 94,958 |  | Reduced −4,311 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $3.9m | 75,160 |  | Reduced −370 |
| [Siena Capital Partners GP, LLC](/funds/1694886.md) | 2026-06-30 | $2.3m | 45,276 |  | Unchanged |
| [Creative Planning](/funds/1540235.md) | 2026-06-30 | $2.1m | 41,249 |  | Added +148 |
| [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $2.0m | 38,488 |  | Added +2,682 |
| [NORTHERN TRUST CORP](/funds/73124.md) | 2026-06-30 | $2.0m | 37,986 |  | Added +2,867 |
| [LIBERTY SQUARE WEALTH PARTNERS LLC](/funds/2057655.md) | 2026-06-30 | $1.9m | 36,243 |  | Unchanged |

## Recent filings

[All 824 filings](/companies/fdbc/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-21 | 18:40 ET | [8-K](/filings/0001437749-26-033095.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-033095 |
| 2026-08-07 | 20:03 ET | [10-Q](/filings/0001437749-26-026575.md) | Quarterly report, period 2026-06-30 | 0001437749-26-026575 |
| 2026-07-22 | 12:59 ET | [8-K](/filings/0001437749-26-024048.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-024048 |
| 2026-05-08 | 20:08 ET | [10-Q](/filings/0001437749-26-015900.md) | Quarterly report, period 2026-03-31 | 0001437749-26-015900 |
| 2026-05-06 | 20:04 ET | [8-K](/filings/0001437749-26-015193.md) | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001437749-26-015193 |
| 2026-04-27 | 20:42 ET | [8-K](/filings/0001437749-26-013488.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001437749-26-013488 |
| 2026-04-22 | 17:05 ET | [8-K](/filings/0001437749-26-012999.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001437749-26-012999 |
| 2026-03-25 | 12:57 ET | [DEF 14A](/filings/0001437749-26-009691.md) | Proxy statement, period 2026-05-05 | 0001437749-26-009691 |
| 2026-03-13 | 20:04 ET | [10-K](/filings/0001437749-26-008215.md) | Annual report, period 2025-12-31 | 0001437749-26-008215 |
| 2026-02-05 | 14:27 ET | [8-K](/filings/0001437749-26-003109.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001437749-26-003109 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001437749-26-008215.md), filed Mar 13, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 1098151
- Tickers: FDBC
- Exchange: Nasdaq
- SIC code: 6021 National Commercial Banks
- State of incorporation: PA
- Filer category: Accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.
